The US FDA has approved multiple NDAs and BLAs in Feb 2020, leading to treatments for patients and advances in health care
The Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 13 novel products so far in 2020, including 10 in Feb and 3 in Jan…
